The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
Kodiak Sciences Inc (KOD)

Kodiak Sciences is a clinical stage biopharmaceutical company focused on researching, developing and commercializing therapeutics to treat high prevalence retinal diseases. Co.'s Antibody Biopolymer Conjugate Platform™ (ABC Platform™) uses molecular engineering to merge the fields of antibody-based and chemistry-based therapies. Co.'s main product candidate, tarcocimab, is an anti-vascular endothelial growth factor antibody biopolymer conjugate being developed for the treatment of retinal vascular diseases including diabetic eye diseases, and wet age-related macular degeneration. Co. has utlized its ABC Platform to build a pipeline of product candidates in various stages of development.

KOD SEC Filing Email Alerts Service

Company Name:  Kodiak Sciences Inc
Website:  www.kodiak.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding KOD:  14
Total Market Value Held by ETFs:  $16.88M
Total Market Capitalization:  $373.00M
% of Market Cap. Held by ETFs:  4.53%
March 28, 2024    6:54 PM Eastern


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Email EnvelopeFree KOD Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Sell (1.00 out of 4)
0th percentile
(ranked lower than approx. 100% of all stocks covered)

Analysts' Target Price:
KOD Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Kodiak Sciences Inc (KOD) Page | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.